ArticleBMC veterinary research2026
Seroprevalence of rift valley fever virus and associated risk factors in small ruminants at human-livestock-wildlife interface within Uganda's conservation areas.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
backgroundFollowing the first laboratory confirmed human Rift Valley Fever Virus (RVFV) outbreak in 48 years, Uganda has continued to detect sporadic outbreaks, particularly within the cattle corridor since 2016. Although wildlife potentially harbors RVFV strains, livestock exposure to RVFV at human-livestock-wildlife interfaces remains underexplored in major Ugandan conservation areas.
methodsA cross-sectional quantitative study was conducted between August, 2022 and March, 2023, at Satellite Research Sites (SRS), located in Bwindi-Mgahinga, Lake Mburo, Queen Elizabeth, Murchison Falls, and Pian Upe conservation areas in Uganda, which were selected for their high human-livestock-wildlife interactions. Using a two-stage sampling design, small ruminants were sampled from randomly selected herds within villages adjacent to the national parks. Blood samples were collected, and analysed with a validated in-house IgG indirect ELISA at the One Health Laboratory. ArcGIS Survey123 was used to capture the field data. Modified Poisson regression for binary outcomes and relative risks estimates were used.
resultsA total of 1,690 small ruminants were sampled: 83.4% goats (caprine species), 16.6% sheep (ovine species). Of these, 92.4% were local breeds and 7.6% were exotic breeds. The females were 88.6% and 11.4% were males, with a mean age of 3 years. Overall RVFV seropositivity for both sheep and goats was 41.1% (695/1690), 95% CI (38.7–43.4%). Seropositivity per species was 42.4% (598/1409) in goats and 34.5% (97/281) in sheep. Exotic breeds and females had higher RVFV seroprevalence rates at 55.5% (71/128) and 41.8% (625/1,495) respectively. Modified Poisson regression analysis revealed that older animals (RR = 1.10, 95% CI: 1.06–1.14, p < 0.001) had higher risk of RVFV seropositivity, whereas local breeds (RR = 0.77, 95% CI: 0.63–0.93, p = 0.009) had reduced exposure risk to RVFV. Low RVFV exposure was evidenced in different management systems of grazing and watering the small ruminants.
conclusionThe high RVFV past exposure among small ruminants justifies the need for further studies to assess recent infections at the human-livestock-wildlife interface. Targeted interventions such as regulated park grazing, integrated vector control, and continuous surveillance should be implemented to minimize RVFV transmission in these high risk areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.